Targeted therapy of hormone receptor-positive breast cancer harboring PIK3CA and AKT1 genetic aberrations

被引：0
|
作者：
Shariati, Maryam
Evans, Kurt W.
Scott, Stephen M.
Chen, Huiqin
Meric-Bernstam, Funda
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
135
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
    Li, Guoli
    Guo, Xinwu
    Chen, Ming
    Tang, Lili
    Jiang, Hui
    Day, Julia X.
    Xie, Yueliang
    Peng, Limin
    Xu, Xunxun
    Li, Jinliang
    Wang, Shouman
    Xiao, Zhi
    Dai, Lizhong
    Wang, Jun
    PLOS ONE, 2018, 13 (09):
  • [42] Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Tissue
    Schmidt, Carolin
    Stoehr, Robert
    Dimitrova, Lora
    Beckmann, Matthias W.
    Ruebner, Matthias
    Fasching, Peter A.
    Denkert, Carsten
    Lehmann, Ulrich
    Vollbrecht, Claudia
    Haller, Florian
    Hartmann, Arndt
    Erber, Ramona
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (07): : 624 - 637
  • [43] PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Baselga, Jose
    Bartlett, John M. S.
    Singhal, Sandeep K.
    Sabine, Vicky S.
    Sims, Andrew H.
    Sahmoud, Tarek
    Dixon, J. Michael
    Piccart, Martine J.
    Sotiriou, Christos
    PLOS ONE, 2013, 8 (01):
  • [44] Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
    Turner, Nicholas
    Dent, Rebecca A.
    O'Shaughnessy, Joyce
    Kim, Sung-Bae
    Isakoff, Steven J.
    Barrios, Carlos
    Saji, Shigehira
    Bondarenko, Igor
    Nowecki, Zbigniew
    Lian, Qinshu
    Reilly, Sarah-Jayne
    Hinton, Heather
    Wongchenko, Matthew J.
    Kovic, Bruno
    Mani, Aruna
    Oliveira, Mafalda
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 565 - 576
  • [45] Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations
    Guillet, Carole
    Rechsteiner, Markus
    Bellini, Elisa
    Choschzick, Matthias
    Moskovszky, Linda
    Dedes, Konstantin
    Papassotiropoulos, Barbel
    Varga, Zsuzsanna
    HUMAN PATHOLOGY, 2020, 98 : 64 - 73
  • [46] PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
    Loi, Sherene
    Haibe-Kains, Benjamin
    Majjaj, Samira
    Lallemand, Francoise
    Durbecq, Virginie
    Larsimont, Denis
    Gonzalez-Angulo, Ana M.
    Pusztai, Lajos
    Symmans, W. Fraser
    Bardelli, Alberto
    Ellis, Paul
    Tutt, Andrew N. J.
    Gillett, Cheryl E.
    Hennessy, Bryan T.
    Mills, Gordon B.
    Phillips, Wayne A.
    Piccart, Martine J.
    Speed, Terence P.
    McArthur, Grant A.
    Sotiriou, Christos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) : 10208 - 10213
  • [47] Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
    Orloff, Mohammed S.
    He, Xin
    Peterson, Charissa
    Chen, Fusong
    Chen, Jin-Lian
    Mester, Jessica L.
    Eng, Charis
    AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 92 (01) : 76 - 80
  • [48] Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer
    Vatte, Chittibabu
    Al Amri, Ali Mohammed
    Cyrus, Cyril
    Chathoth, Shahanas
    Alsayyah, Ahmed
    Ahmad, Arafat
    Akhtar, Mohammed Shakil
    Alrashidi, Nada Fehaid
    Jayaseeli, Nithya
    Al Wadani, Hamed
    Al Zahrani, Alhussain
    Al Ali, Amein Kadhem
    ONCOLOGY LETTERS, 2019, 18 (03) : 2427 - 2433
  • [49] Synergistic anticancer Effects of low-dose Vinorelbine in Combination with Alpelisib in Hormone Receptor-positive PIK3CA mutant Breast Carcinoma Cells
    Krajnak, S.
    Trier, J. P.
    Anic, K.
    Loewe, A.
    Schmidt, M.
    Battista, M. J.
    Hasenburg, A.
    Brenner, W.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E110 - E110
  • [50] Activating mutations in AKT1/PIK3CA are associated with poor clinical outcomes in metastatic prostate cancer (mPC)
    Fu, S. Y. F.
    Murtha, A.
    Herberts, C.
    Yip, S.
    Angeles, A.
    Hotte, S. J.
    Alshangiti, A.
    Tran, B.
    Taavitsainen, S.
    Annala, M.
    Saad, F.
    Iqbal, N. N.
    Wyatt, A. W.
    Chi, K. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 347 - 347
12345